SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2011 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2012.
  • 2
    Massie AB, Caffo B, Gentry SE, Hall EC, Axelrod DA, Lentine KL, et al. MELD exceptions and rates of waiting list outcomes. Am J Transplant 2011;11:2362-2371.
  • 3
    Renz JF. A critical analysis of liver allograft utilization from the US deceased donor pool. Liver Transpl 2010;16:543-547.
  • 4
    Kinkhabwala M, Lindower J, Reinus JF, Principe AL, Gaglio PJ. Expedited liver allocation in the United States: a critical analysis. Liver Transpl 2013;19:1159-1165.
  • 5
    Lai JC, Roberts JP, Vittinghoff E, Terrault NA, Feng S. Patient, center and geographic characteristics of nationally placed livers. Am J Transplant 2012;12:947-953.
  • 6
    Lai JC, Feng S, Vittinghoff E, Roberts JP. Offer patterns of nationally placed livers by donation service area. Liver Transpl 2013;19:404-410.
  • 7
    Diaz GC, Renz JF. Liver allograft utilization patterns in the United States. Paper presented at: ILTS 19th Annual International Congress; June 12-15, 2013; Sydney, Australia.
  • 8
    Gerber DA, Arrington CJ, Taranto SE, Baker T, Sung RS. DonorNet and the potential effects on organ utilization. Am J Transplant 2010;10(pt 2):1081-1089.
  • 9
    Washburn K, Olthoff K. Truth and consequences: the challenge of greater transparency in liver distribution and utilization. Am J Transplant 2012;12:808-809.
  • 10
    Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 2005;242:556-563.
  • 11
    Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chestovich P, Milgrom ML, et al. No difference in clinical transplant outcomes for local and imported liver allografts. Liver Transpl 2009;15:640-647.
  • 12
    Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg 2008;248:599-607.
  • 13
    Salvalaggio PR, Dzebisashvili N, MacLeod KE, Lentine KL, Gheorghian A, Schnitzler MA, et al. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 2011;17:233-242.
  • 14
    Axelrod DA, Gheorghian A, Schnitzler MA, Dzebisashvili N, Salvalaggio PR, Tuttle-Newhall J, et al. The economic implications of broader sharing of liver allografts. Am J Transplant 2011;11:798-807.
  • 15
    Volk ML, Hagan M. Organ quality and quality of life after liver transplantation. Liver Transpl 2011;17:1443-1447.
  • 16
    Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8:419-425.
  • 17
    Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
  • 18
    Desai AP, Te HS, Aronsohn A, Gautham Reddy K, Reau N, Jensen DM, et al. High-risk allografts are a cost-effective mechanism for decreasing wait list mortality. Paper presented at: 63rd Annual Meeting of the American Association for the Study of Liver Diseases; November 9-13, 2012; Boston, MA.
  • 19
    Witkowski P, Diaz G, Olaitan O, Ostrega D, Cummings R, Rodriguez J, et al. What does it really cost to be an “aggressive” liver transplant center? Paper presented at: ILTS 18th Annual International Congress; May 16-19, 2012; San Francisco, CA.